Objective: To assess whether alterations in the stromal cell-derived factor-1 (SDF-1)/CXCR4 occur in patients with primary myelofibrosis (PMF) and in Gata1 low mice, an animal model for myelofibrosis, and whether these abnormalities might account for increased stem/progenitor cell trafficking.
Materials And Methods: In the mouse, SDF-1 mRNA levels were assayed in liver, spleen, and marrow. SDF-1 protein levels were quantified in plasma and marrow and CXCR4 mRNA and protein levels were evaluated on stem/progenitor cells and megakaryocytes purified from the marrow. SDF-1 protein levels were also evaluated in plasma and in marrow biopsy specimens obtained from normal donors and PMF patients.
Results: In Gata1 low mice, the plasma SDF-1 protein was five times higher than normal in younger animals. Furthermore, SDF-1 immunostaining of marrow sections progressively increased with age. Similar abnormalities were observed in PMF patients. In fact, plasma SDF-1 levels in PMF patients were significantly higher (by twofold) than normal (p < 0.01) and SDF-1 immunostaining of marrow biopsy specimens demonstrated increased SDF-1 deposition in specific areas. In two of the patients, SDF-1 deposition was normalized by curative therapy with allogenic stem cell transplantation. Similar to what already has been reported for PMF patients, the marrow from Gata1 low mice contained fewer CXCR4 pos CD117 pos cells and these cells expressed low levels of CXCR4 mRNA and protein.
Conclusion: Similar abnormalities in the SDF-1/CXCR4 axis are observed in PMF patients and in the Gata1 low mice model of myelofibrosis. We suggest that these abnormalities contribute to the increased stem/progenitor cell trafficking observed in this mouse model as well as patients with PMF.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747096 | PMC |
| http://dx.doi.org/10.1016/j.exphem.2007.10.001 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Genetic modifications of reactivate HbF production in β-thalassemia/HbE.
Heliyon
September 2024
Division of Clinical Microscopy, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand.
Article Synopsis
- Reactivating fetal hemoglobin (HbF) has potential benefits for patients with β-thalassemia by improving their clinical symptoms.
- Prolyl hydroxylase domain enzymes (PHDs), particularly PHD2, are important for oxygen sensing and maintaining the stability of HIF-α; inhibiting these enzymes can increase HbF production in cells.
- Using CRISPR to modify PHD2’s functional regions resulted in lower PHD2 expression and higher HbF levels in severe β-thalassemia, highlighting a new regulatory mechanism that could be targeted for therapeutic purposes.
Aspirin reduces Ponatinib-induced cardiovascular toxic phenotypes and death in zebrafish.
Biomed Pharmacother
November 2024
State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, Macau 999078, China. Electronic address:
Article Synopsis
- Ponatinib (Iclusig) is a medication used to treat specific types of leukemia, but it can cause serious cardiovascular problems that may impact patient survival rates.
- The study aimed to determine how Aspirin could help mitigate these cardiovascular side effects in zebrafish models.
- Results showed that while Ponatinib caused harmful cardiac issues and reduced survival, Aspirin significantly lowered the toxicity associated with Ponatinib and improved zebrafish survival rates.
Key Genes and under Acute High-Altitude Exposure: A Gene Expression and Network Analysis Based on Expression Profile Data.
Genes (Basel)
August 2024
School of Information Science and Engineering, Lanzhou University, Lanzhou 730000, China.
High-altitude acclimatization refers to the physiological adjustments and adaptation processes by which the human body gradually adapts to the hypoxic conditions of high altitudes after entering such environments. This study analyzed three mRNA expression profile datasets from the GEO database, focusing on 93 healthy residents from low altitudes (≤1400 m). Peripheral blood samples were collected for analysis on the third day after these individuals rapidly ascended to higher altitudes (3000-5300 m).
View Article and Find Full Text PDFPrenatal Manifestation of Transient Abnormal Myelopoiesis: Case Report and Review of the Literature.
J Clin Med
August 2024
I Department of Obstetrics and Gynecology, Medical University of Warsaw, 02-091 Warsaw, Poland.
Article Synopsis
- - This text discusses a rare case of transient abnormal myelopoiesis (TAM), a hematologic disorder usually seen in babies with trisomy 21, identified in a newborn with a normal karyotype.
- - The case involved a pregnant woman who presented with reduced fetal movements and was found to have indicators of fetal distress, prompting an emergency cesarean section that resulted in the delivery of a female newborn with notable blood abnormalities.
- - The study emphasizes the importance for obstetricians to recognize signs like elevated middle cerebral artery peak systolic velocity and hepatosplenomegaly, which could indicate fetal blood disorders, and distinguishes these from other conditions like infections or isoimmunization.
Article Synopsis
- * JAK1/2 inhibitor Ruxolitinib was specifically noted to shrink spleen size, while the drugs Aplidin and SB431542/AVID200 improved platelet counts and various inhibitors reduced tissue fibrosis.
- * The research suggests that combining Ruxolitinib with treatments targeting hematopoietic stem cells or inflammation could enhance therapeutic outcomes for myelofibrosis.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!